Identifying tumor neoantigens through multi-omics sequencing

We collected fresh tumor tissues, adjacent normal tissues, and peripheral blood from five patients (2 lung cancer patients, 2 breast cancer patients and 1 pancreatic cancer patient), and performed whole-exome sequencing (WES) on both tumor and adjacent tissues, RNA-seq on the tumor tissues, and TCR-seq on the peripheral blood.